The pharmaceutical drug delivery market is on the brink of a significant transformation. According to the recent report, "Pharmaceutical Drug Delivery Market Size, Growth by Route of Administration (Oral, Injectors, Implantable, Syrups, Gels, Pulmonary, Solutions, Tablets, Syringes), Application (Cancer, Diabetes), Facility of Use (Hospitals) - Global Forecast to 2026", this market is projected to soar to an impressive USD 2,206.5 billion by 2026, growing at a CAGR of 5.9%. This growth is a testament to the continuous advancements and innovations in drug delivery technologies aimed at enhancing patient care and treatment outcomes.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1085
Driving Forces Behind the Growth
Innovations in Drug Delivery Technologies
Drug delivery is a critical aspect of modern medicine, encompassing methods of administering pharmaceutical compounds to achieve the desired therapeutic effect safely and effectively. Innovations in this field have led to several benefits, including increased convenience, ease of use, and improved patient compliance. Pharmaceutical and biopharmaceutical companies are heavily investing in research and development (R&D) to create new molecules for various therapeutic applications and develop advanced drug delivery platforms. This focus on innovation is crucial for delivering high-quality and groundbreaking products to the market.
Addressing Market Challenges
Despite the promising growth, the pharmaceutical drug delivery market faces certain challenges. The risk of needlestick injuries and the pressure on drug pricing are notable concerns that could potentially hinder market expansion. Companies are actively working to mitigate these issues through the development of safer delivery methods and cost-effective solutions.
Market Segmentation Insights
Route of Administration:
The market is segmented based on the route of administration into oral, pulmonary, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery. In 2020, the oral drug delivery segment held the largest market share. This dominance is attributed to the convenience, patient preference, cost-effectiveness, and ease of large-scale manufacturing associated with oral dosage forms.
Application Areas:
When segmented by application, the infectious diseases segment emerged as the largest market share holder. This can be linked to the rising prevalence of infectious diseases globally and the increasing number of FDA approvals for related drugs. Other significant application areas include cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, and autoimmune diseases.
Facility of Use:
Hospitals accounted for the largest share of the pharmaceutical drug delivery market in 2020. The significant number of inpatient and outpatient visits, along with the growing need for large volumes of drugs and delivery devices, drives this segment. Additionally, the increasing incidence of chronic diseases, aging population, and the rising number of hospitalizations and surgical procedures contribute to this growth.
Regional Growth Prospects
The Asia Pacific region is poised to be the fastest-growing market for pharmaceutical drug delivery during the forecast period. Factors such as a rapidly aging population, rising prevalence of chronic diseases, increased healthcare expenditure, and robust R&D activities are driving this growth. Technological collaborations, favorable reimbursement policies, and rising disposable incomes in countries like China and India further bolster the market's expansion in this region.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1085
Key Market Players:
The pharmaceutical drug delivery market is highly competitive, with several major players driving innovation and growth. Key companies include Johnson & Johnson (US), Novartis International AG (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Pfizer Inc. (US), Bayer AG (Germany), and many others. These companies are at the forefront of developing cutting-edge drug delivery technologies and expanding their market presence through strategic collaborations and investments.
Conclusion:
The pharmaceutical drug delivery market is set for remarkable growth, driven by technological advancements and increasing demand for effective and convenient drug delivery methods. With continuous innovations and strategic investments, the market is poised to significantly enhance patient care and treatment outcomes, making a substantial impact on global healthcare. As we look towards 2026, the future of pharmaceutical drug delivery promises to be dynamic and transformative, offering new possibilities for improved health and well-being.
Monday, June 24, 2024
The Future of Medicine: Exploring the Pharmaceutical Drug Delivery Market's Growth by 2026
Booming Pharmaceutical Excipients Market Set to Reach $13.9 Billion by 2028
The pharmaceutical excipients market is on an impressive growth trajectory, projected to soar to $13.9 billion by 2028 from its 2023 valuation of $10.0 billion. This robust expansion, at a compound annual growth rate (CAGR) of 6.8%, highlights the sector's dynamic evolution driven by multiple key factors.
Key Drivers of Market Growth:
Increasing Demand for Generic Drugs: As healthcare systems worldwide aim to reduce costs, the demand for generic pharmaceuticals has surged. Excipients, which are crucial in the formulation of these drugs, are in higher demand than ever.
Rising R&D Investments: There's a significant push in research and development for novel excipients. These innovations are designed to enhance drug stability, improve patient compliance, and facilitate new drug delivery methods.
Patient-Centric Formulations: The pharmaceutical industry is increasingly focusing on patient-centric formulations. Customized excipient solutions that cater to specific patient needs are becoming more common, driving market growth.
Strategic Collaborations: Partnerships between pharmaceutical companies and excipient manufacturers are on the rise. These collaborations aim to develop tailored solutions that enhance the efficacy and safety of pharmaceutical products.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=956
Market Segmentation Insights
By Product:
Organic Chemicals: Dominating the market, organic chemicals such as oleochemicals and carbohydrates are preferred due to their non-toxic nature. This segment's growth is pivotal in driving the overall market.
Inorganic Chemicals: Including substances like calcium carbonate, these play a vital role but are secondary to organic compounds in market share.
By Functionality:
Fillers and Diluents: This segment held the largest market share in 2022. Fillers and diluents are essential in giving bulk and consistency to solid oral dosage forms, particularly tablets, which remain the most popular dosage form.
Lubricants and Glidants: Expected to grow at the fastest rate, these excipients improve the flow properties of formulations, making the manufacturing process more efficient and ensuring consistency in drug delivery.
Regional Market Dynamics:
The Asia Pacific region is anticipated to exhibit the fastest growth during the forecast period. Factors contributing to this rapid expansion include:
Cost Advantages: Lower labor and manufacturing costs in countries like China and India attract significant investment from pharmaceutical companies.
Rising Prevalence of Diseases: An increase in lifestyle-related and age-related diseases drives demand for pharmaceutical products.
Government Initiatives: Enhanced healthcare infrastructure and supportive government policies in the region further stimulate market growth.
Leading Market Players:
The global pharmaceutical excipients market is highly competitive, with key players such as:
# International Flavors & Fragrances Inc. (US)
# Ashland Inc. (US)
# Evonik Industries AG (Germany)
# BASF SE (Germany)
# Kerry Group Plc (Ireland)
# Roquette Frères (France)
# Merck KgaA (Germany)
# Associated British Foods Plc (UK)
# ADM (US)
# Wacker Chemie AG (Germany)
These companies are continuously innovating and expanding their product portfolios to maintain and enhance their market positions.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=956
Conclusion:
The pharmaceutical excipients market is poised for significant growth, driven by increasing demand for generic drugs, substantial R&D investments, and the rising importance of patient-centric formulations. With the Asia Pacific region leading the charge, the market's future looks promising, presenting numerous opportunities for stakeholders across the value chain.
Wednesday, June 12, 2024
Exploring the Global Growth Opportunities in Booming Peptide Synthesis Market
In recent years, peptides have become the cornerstone of numerous medical and biotechnological advancements. These short chains of amino acids play crucial roles in various biological functions and have found their way into therapeutic drugs, diagnostics, and research tools. The global peptide synthesis market is riding this wave of innovation, poised to grow from USD 601 million in 2023 to USD 859 million by 2028, at a CAGR of 7.4%. Let’s delve into the key drivers, segments, and future prospects of this dynamic market.
Key Drivers of Market Growth:
The growth of the peptide synthesis market can be attributed to several critical factors:
# Increasing Demand for Peptides: Peptides are increasingly used in pharmaceuticals due to their high specificity and potency, low toxicity, and ability to target a wide range of diseases.
# Technological Advancements: Innovations in synthesis technologies, such as solid-phase and hybrid techniques, have streamlined the production process, making it more efficient and cost-effective.
# Expanding Therapeutic Applications: Peptides are being explored for treating various conditions, including cancer, metabolic disorders, and infectious diseases.
# Rising R&D Investments: Significant investments in research and development are driving advancements in peptide therapeutics and synthesis methodologies.
# Supportive Market Ecosystem: The growth of contract research and manufacturing organizations (CROs and CMOs) has bolstered the market, providing essential services to biotech and pharma companies.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158927365
Market Segmentation:
The peptide synthesis market is segmented based on product & service, technology, end user, and region. Here’s a closer look at these segments:
Product & Service:
# Reagents: The reagents segment, including resins, amino acids, and dyes, accounted for the largest share of the market in 2022. This is driven by the high demand for peptide-based therapeutics and the availability of diverse synthesis reagents.
# Equipment: This includes peptide synthesizers, chromatography systems, and lyophilizers. Advances in automation and technology have made equipment more efficient, though high costs remain a challenge.
# Services: Outsourcing synthesis to specialized firms provides flexibility and access to advanced technologies without significant capital investment.
Technology:
# Solid-Phase Peptide Synthesis (SPPS): Dominating the market, SPPS offers numerous advantages such as ease of operation, automation potential, and the ability to produce long peptides efficiently.
# Solution-Phase Peptide Synthesis: While less common, this method is used for specific applications where SPPS may not be suitable.
# Hybrid & Recombinant Technologies: Combining the best of both worlds, these technologies are gaining traction for their versatility and efficiency.
End User:
# Pharmaceutical and Biotechnology Companies: These entities are the primary consumers of peptide synthesis products and services, driving innovation and development.
# Contract Research Organizations (CROs): CROs are essential partners in research and drug development, providing expertise and resources.
# Academic and Research Institutions: These institutions contribute significantly to the advancement of peptide science through fundamental research.
Regional Insights:
Geographically, the peptide synthesis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
# North America: Holding the largest market share, North America's growth is driven by substantial R&D investments and a robust pharmaceutical industry.
# Asia Pacific: Expected to grow at the highest CAGR, this region benefits from rising R&D expenditure, increasing prevalence of chronic diseases, and significant investments in drug discovery and development.
# Europe, Latin America, and the Middle East & Africa: These regions also show promising growth, with expanding biotech sectors and supportive regulatory environments.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=158927365
Leading Market Players:
Prominent companies shaping the peptide synthesis market include
# Thermo Fisher Scientific, Inc. (US)
# Merck KGaA (Germany)
# Kaneka Corporation (Japan)
# GenScript Biotech Corporation (China)
# Bachem Holding AG (Switzerland)
These companies are at the forefront of innovation, driving the market with new technologies, products, and services.
Conclusion:
The peptide synthesis market is on a robust growth trajectory, underpinned by technological advancements, increasing demand for peptide-based therapeutics, and substantial R&D investments. As the market continues to evolve, it promises to play a pivotal role in the future of medicine, offering new possibilities for treatment and research. Stakeholders across the pharmaceutical, biotech, and research sectors will find ample opportunities to innovate and grow in this dynamic landscape.
Related Studies:
Peptide Synthesis Market – Revenue Growth Trends by 2028
https://www.marketsandmarketsblog.com/peptide-synthesis-market-revenue-growth-trends-by-2028.html
Peptide Synthesis Market worth $859 million | MarketsandMarkets
https://www.prnewswire.com/news-releases/peptide-synthesis-market-worth-859-million--marketsandmarkets-301874015.html
Tuesday, June 11, 2024
Radiating Success: The Growing Market for Radiation Shielding Materials
In the rapidly advancing world of medical technology, the radiation shielding material market is experiencing significant growth. Estimated to be worth USD 714 million in 2023, this market is projected to reach USD 980 million by 2028, expanding at a robust CAGR of 6.5% during this period. This surge is driven by the increasing use of nuclear medicine and radiation therapy for both diagnosis and treatment, particularly in the context of rising cancer incidences globally.
Driving Forces Behind Market Growth
1. Rising Demand for Particle Therapy:
Particle therapy, notably proton therapy, is becoming a preferred method for cancer treatment due to its precision and reduced side effects compared to conventional photon therapy. The adoption of such advanced technologies is growing, with the number of particle therapy centers worldwide increasing from 66 in 2017 to 115 by May 2022. This trend is expected to continue, significantly boosting the demand for radiation shielding materials.
2. Increasing Cancer Cases:
With the global incidence of cancer on the rise, there is a corresponding increase in the need for radiation-based treatments and diagnostics. This trend is particularly notable in regions with high rates of cancer and substantial investments in healthcare infrastructure, such as North America and Europe.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=188449426
Market Dynamics
Opportunities:
The market for radiation shielding materials is ripe with opportunities, particularly due to increased private investments in cancer research and the development of advanced radiotherapy technologies. Governments and private entities are pouring funds into cancer treatment infrastructure, exemplified by significant investments like the USD 45.5 million by the Australian Government for regional radiation treatment centers.
Challenges:
However, the market is not without its challenges. The high cost of lead and other shielding materials poses a significant restraint. Additionally, a shortage of skilled oncologists and radiologists can limit the effective use of radiation therapy technologies, impacting the demand for shielding materials.
Key Segments and Regional Insights
Product Types:
Electromagnetic Radiation Shielding: Expected to grow the fastest due to the rising use of diagnostic imaging procedures and the increasing prevalence of target diseases like cancer and Alzheimer’s.
Particle Radiation Shielding: Continues to be critical, driven by the expanding use of particle therapy.
Applications:
Diagnostic X-ray Room Shielding: Dominates the market due to the extensive use of X-ray technology in diagnostic centers and hospitals.
CT Scanner and MRI Room Shielding: Also significant, with growing installations in healthcare facilities.
Regional Insights:
North America: Leading the market, driven by substantial government and private sector investments in cancer treatment facilities and advanced diagnostic technologies.
Europe and Asia Pacific: Also showing significant growth, with increasing healthcare infrastructure development and rising cancer treatment needs.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=188449426
Leading Market Players:
Prominent companies in this market include ETS-LINDGREN, Nelco Worldwide, Infab Corporation, Burlington Medical, and MarShield, among others. These companies are at the forefront of innovation, offering a wide range of products that cater to the diverse needs of the radiation shielding market.
Future Outlook:
The future of the radiation shielding material market looks promising, with ongoing advancements in radiotherapy technologies and increasing investments in healthcare infrastructure. As the demand for effective cancer treatment continues to rise, the market for radiation shielding materials is expected to grow, offering numerous opportunities for innovation and expansion.
Exploring the Future of the Liquid Handling System Market: Trends, Growth Drivers, and Key Players
The liquid handling system market is poised for significant growth in the coming years, driven by advancements in the pharma-biotech sector, increased R&D expenditure, and the rising focus on precision and automation. According to the latest report by MarketsandMarkets, the market is projected to reach USD 5.8 billion by 2027, up from USD 4.6 billion in 2022, reflecting a CAGR of 4.6% during the forecast period.
Market Overview and Key Segments:
The comprehensive report titled "Liquid Handling System Market by Product (Pipette, Consumables, Liquid Handling Workstations, Burettes, Software), Type (Automated, Electronic, Manual), Application (Drug Discovery, Clinical Diagnostics), End User (Research Institutes) - Global Forecast to 2027" provides detailed insights into market dynamics, segmented across various dimensions.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=192124302
Growth Drivers:
Several factors are propelling the growth of the liquid handling system market:
# Industrial Growth in Pharma-Biotech Sector: The ongoing expansion in pharmaceutical and biotechnology industries significantly boosts demand for advanced liquid handling systems.
# Increased R&D Expenditure: Higher investment in research and development by biotech and pharmaceutical companies is driving market growth.
# Focus on Precision and Automation: The need for precise and accurate data in scientific research, coupled with increasing labor costs, is pushing for more automated solutions.
# Favorable Funding Scenarios: Government and private sector funding in life sciences research is further supporting market expansion.
Product Segmentation:
The market is segmented by product type into pipettes, consumables, liquid handling workstations, microplate reagent dispensers, microplate washers, burettes, software, and other products. Among these, the pipettes segment held the largest market share in 2021, driven by the high demand in drug discovery and genomic and proteomic research.
Technological Advancements:
Technological segmentation of the market includes automated, electronic, and manual systems. Automated liquid handling systems dominated the market in 2021 due to their widespread use in pharmaceutical and biotechnology companies. These systems are preferred for their speed, accuracy, reliability, and consistency in operations.
Application Areas:
The liquid handling system market is also categorized by application into drug discovery, clinical diagnostics, genomics, proteomics, and other applications. Drug discovery emerged as the leading segment in 2022, primarily due to increased investment in drug development and the critical role of liquid handling in various research processes such as sample preparation, assay setup, high-throughput screening, and toxicity studies.
Regional Insights:
Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America led the market in 2021, thanks to significant advances in biotechnology and pharmaceutical industries and substantial investment and government funding for research. The region's well-established infrastructure and presence of key industry players further contribute to its dominant position.
Major Players:
The liquid handling system market is highly consolidated, with major players including:
# Thermo Fisher Scientific Inc. (US)
# Danaher Corporation (US)
# Eppendorf (Germany)
# PerkinElmer Inc. (US)
# Agilent Technologies, Inc. (US) and many more.
These companies are at the forefront of innovation, continuously developing advanced liquid handling solutions to meet the evolving needs of the life sciences industry.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=192124302
Conclusion:
The liquid handling system market is on a robust growth trajectory, fueled by technological advancements, increased R&D investments, and a growing focus on automation. As the industry continues to evolve, the integration of advanced liquid handling systems in research and diagnostics will play a critical role in driving scientific discoveries and improving healthcare outcomes. Stay updated with the latest trends and insights by exploring the detailed report from MarketsandMarkets.
Monday, June 10, 2024
Fill Finish Manufacturing Market - Global Industry Growth Landscape
Main Objectives of the Study:
# Define, describe, and forecast the fill-finish manufacturing market by product, end-user, and region.
# Provide detailed information on the major factors influencing market growth (drivers, restraints, opportunities, and challenges).
# Analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall fill-finish manufacturing market.
# Identify opportunities for stakeholders and provide details on the competitive landscape for market leaders.
# Forecast market segment sizes across six regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
# Profile key players and analyze their market shares and core competencies.
# Track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions.
# Benchmark market players using the proprietary “Company Evaluation Matrix” framework, analyzing players on business and product excellence strategy parameters.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6249609
Primary Research:
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants. These interviews aimed to obtain and verify critical qualitative and quantitative information and assess future market prospects. Various primary sources from both the supply and demand sides of the market were interviewed. The breakdown of primary respondents is as follows:
# Tier 1: Companies with total revenue >USD 1 billion
# Tier 2: Companies with total revenue between USD 500 million to USD 1 billion
# Tier 3: Companies with total revenue <USD 500 million
Secondary Research:
The secondary research focused on identifying and collecting extensive technical, market-oriented, and commercial information about the fill-finish manufacturing market. Sources for this study included the World Health Organization (WHO), National Institutes of Health (NIH), National Institute of Standards and Technology (NIST), International Society for Pharmaceutical Engineering (ISPE), BioPharm International, US Food and Drug Administration (US FDA), European Medicines Agency (EMA), Parenteral Drug Association (PDA), National Center for Biotechnology Information (NCBI), International Trade Centre (ITC), press releases, company websites, magazines, paid databases, World Bank, annual reports, SEC filings, industry conferences, scholarly journals, investor presentations, expert interviews, and MarketsandMarkets analysis.
Market Size Estimation:
The global size of the fill-finish manufacturing market was estimated using multiple approaches. A detailed market estimation approach was followed to validate the market value and dependent submarkets. These methods were also used to estimate the sizes of various subsegments. The research methodology included:
# Identification of major industry players through extensive primary and secondary research.
# Determination of product and company revenues from fill-finish manufacturing businesses through secondary research and primary analysis.
# Verification of all percentage shares, splits, and breakdowns using secondary sources and primary sources.
Data Triangulation:
After estimating the overall market size, the total market was segmented into various segments and subsegments. Data triangulation and market breakdown procedures were employed to finalize the statistics for all segments and subsegments, considering factors and trends from both the demand and supply sides.
Projected Surge in Global Revenue:
The size of global fill finish manufacturing market in terms of revenue was estimated to be worth $16.7 billion in 2024 and is poised to reach $25.7 billion by 2029, growing at a CAGR of 8.9% from 2024 to 2029.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=6249609
Key Stakeholders:
# Fill-finish manufacturing product manufacturing companies
# National and regional research boards and organizations
# Research and development companies
# Contract research organizations (CROs)
# Contract manufacturing organizations (CMOs)
# Contract research, development, and manufacturing organizations (CDMOs)
# Medical device companies
# Biotechnology companies
# Research laboratories and academic institutes
# Market research and consulting firms
# Regulatory bodies
Leading Companies:
The global fill finish manufacturing markets comprises of many key market players competing for markets shares like Syntegon Technology GmbH (Germany), I.M.A. S.P.A. (Italy), BD (US), West Pharmaceutical Services, Inc. (US), Gerresheimer AG (Germany), AptarGroup, Inc. (US), Dätwyler Holding Inc. (Belgium), Berry Global, Inc. (US), Stevanato Group S.p.A. (Italy), OPTIMA (Germany), Bausch+Ströbel (Germany), Groninger & Co. Gmbh (Germany), SGD PHARMA (France), SCHOTT (Germany), Nipro Corporation (Japan), Bausch Advanced Technology Group (US) and Maquinaria Industrial Dara, Sl (Spain).
Friday, June 7, 2024
Dental Consumables: A Thriving Market of Innovation and Growth
The global dental consumables market is on a trajectory of remarkable growth, with its revenue poised to surge from an estimated $36.3 billion in 2024 to a whopping $54.6 billion by 2029. This represents a robust compound annual growth rate (CAGR) of 8.5%, reflecting the dynamic advancements and rising demand in the dental industry.
A Snapshot of Market Dynamics
In 2023, North America claimed the second-largest share of the dental consumables market, driven by groundbreaking innovations such as dental lasers, CAD/CAM technology, and advanced dental implants. These technological advancements have revolutionized dental procedures, making them more efficient, less invasive, and increasingly accessible, thus boosting the market's expansion.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=699
Drivers of Growth
Minimally Invasive Dentistry: There's a growing preference for minimally invasive dental procedures among both patients and dentists. This shift is propelling the demand for consumables that facilitate such procedures, including adhesive materials and bonding agents. Moreover, government initiatives aimed at enhancing oral healthcare infrastructure and increasing insurance coverage for dental treatments are making these procedures more accessible and affordable, further driving market growth.
Cosmetic Dentistry Boom: The rising demand for aesthetic dental enhancements is another significant growth driver. Products like teeth whitening agents, veneers, and orthodontic materials are seeing a surge in demand as more people seek to improve their appearance. High-quality materials like advanced composites and porcelain are enhancing the outcomes of cosmetic procedures, boosting patient satisfaction and market growth.
Market Challenges
High Cost of Treatments: Dental procedures and consumables can be expensive, particularly in regions lacking comprehensive dental insurance coverage. This can deter patients from seeking necessary dental care, thus impacting market growth. The out-of-pocket expenses for dental care in such regions remain a significant burden, limiting the market's expansion.
Regulatory Hurdles: The dental consumables market is highly regulated to ensure patient safety and product efficacy. Obtaining regulatory approvals can be time-consuming and costly, delaying product launches and increasing development expenses. This regulatory landscape can pose a challenge, especially for smaller players in the industry.
Opportunities on the Horizon
Cosmetic Dentistry: The demand for cosmetic dental procedures continues to rise, driven by an increasing awareness of oral health and the desire for better appearance. Innovations in dental materials and techniques are enhancing the efficacy and outcomes of these procedures, making them more popular and accessible.
Digital Dentistry: The integration of digital technologies such as CAD/CAM systems and 3D printing is revolutionizing dental services. These technologies are driving demand for advanced consumables and are expected to significantly shape the future of dental care.
Regional Insights
Europe is expected to lead the global dental consumables market with the highest CAGR during the forecast period. The region's well-established healthcare systems, rising prevalence of dental diseases among the aging population, and technological advancements in dental materials and techniques are key factors driving this growth. However, economic disparities and variations in healthcare coverage across different European countries can pose challenges.
Key Players and Competitive Landscape
The dental consumables market is becoming increasingly competitive with new entrants and established players vying for market share. Major companies like Institut Straumann AG, Envista Holdings Corporation, and Dentsply Sirona Inc. are leading the market with continuous innovations and strategic partnerships.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=699
Conclusion
The dental consumables market is set for substantial growth, driven by technological advancements, rising demand for minimally invasive and cosmetic dental procedures, and supportive government initiatives. Despite challenges such as high treatment costs and regulatory hurdles, the market's future looks promising, with significant opportunities for innovation and expansion. As dental care continues to evolve, the dental consumables market will play a crucial role in enhancing the quality and accessibility of dental treatments worldwide.
Thursday, June 6, 2024
Digital Twins in Healthcare Industry to Gain Major Revenue Surge by 2028
Overview of This Study:
This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.
Major Growth Influencing Factors:
The rising demand of technologically advanced solutions and the growing emphasis of digital twin technology supporting various healthcare applications are some of the critical factors offering opportunities to the market. However, lack of technical expertise and data management issues are key factors challenging the growth of the market.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74014375
Market Size Estimation:
The total size of the market was arrived at after data triangulation through the two approaches mentioned below. After the completion of each approach, the weighted average of these approaches was taken based on the level of assumptions used in each approach.
Projected Surge in Global Revenue:
The size of global digital twins in healthcare market in terms of revenue was estimated to be worth $1.6 billion in 2023 and is poised to reach $21.1 billion by 2028, growing at a CAGR of 67.0% from 2023 to 2028.
Data Triangulation:
The size of the market was estimated through segmental extrapolation using the bottom-up approach. The methodology used is as given below:
# Revenues for individual companies were gathered from public sources and databases.
# Shares of leading players in the market were gathered from secondary sources to the extent available. In some instances, shares of digital twins in healthcare businesses have been ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, selling price, and geographic reach & strength.
# Individual shares or revenue estimates were validated through interviews with experts.
The total revenue in the digital twins in healthcare market was determined by extrapolating the Market share data of major companies.
Opportunity: Increasing focus on cutting-edge real-time data analytics
Digital twins generate vast amounts of data that can be analyzed in real-time to provide insights into patient health, resource utilization, and operational efficiency. For example, a hospital's digital twins can collect and analyze real-time data from various sources, including medical devices, electronic health records, and IoT sensors, to detect potential equipment failures, predict patient outcomes, and identify areas of operational inefficiency. Real-time data analytics can also help healthcare providers make informed treatment plans, resource allocation, and patient care decisions. The base of the complete digital twins technology is data analytics. Once established, digital twins and analytics will provide more accurate diagnostics, and optimal and predictive operations. These advancements have facilitated digital twins technology in healthcare, which is expected to create potential in the coming years.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=74014375
Leading Companies Operating in This Industry:
Prominent companies in this market include Siemens Healthineers AG (Germany), Dassault Systèmes (France), Microsoft (US), Koninklijke Philips N.V. (Netherlands), Faststream Technologies (US), Twin LTD (US), IBM (US), NVIDIA Corporation (US), GE Healthcare (US), NUREA (France), ANSYS, Inc. (US), Rescale, Inc. (US), Predictiv (US), Verto Health (Canada), PrediSurge (France), Qbio (US), Virtonomy GmbH (Germany), Unlearn AI (US), Atos SE (France), ThoughtWire (Canada), Amazon Web Services, Inc.(US), Oracle(US), PTC (US), SAP (Germany), Sim and Cure (France).
Sleep Apnea Devices Market - Major Growth Driving Factors
Overview of This Study:
The objective of the study is analyze the key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies. To track companies developments such as acquisitions, product launches, expansions, collaborations, agreements and partnerships of the leading players, the competitive landscape of the sleep apnea devices industry to analyzes market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were use to estimate the market size. To estimate the market size of segments and subsegments the market breakdown and data triangulation were used.
Market Size Estimation:
All major product manufacturers offering various sleep apnea were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value sleep apnea devices market was also split into various segments and subsegments at the region and country level based on:
# Product mapping of various manufacturers for each type of sleep apnea devices industry at the regional and country-level
# Relative adoption pattern of each sleep apnea devices market among key application segments at the regional and/or country-level
# Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country-level.
# Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719
Revenue Growth Dynamics:
The size of global sleep apnea devices market in terms of revenue was estimated to be worth $5.8 billion in 2023 and is poised to reach $8.0 billion by 2028, growing at a CAGR of 6.5% from 2023 to 2028.
Data Triangulation:
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact sleep apnea statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Sleep apnea devices industry.
Market Definition:
Sleep apnea involves abnormal pauses in breathing, ranging from a few seconds to minutes, or the occurrence of an abnormally slow breathing rate. Sleep apnea devices are used to force air into the nasal passages at high pressure to overcome obstructions in the airway and stimulate normal breathing.
Opportunity: Increasing focus on telemedicine, mHealth and AI
Several studies have reported that a main predictive factor for long-term CPAP compliance is patient adherence in the first few weeks of treatment. Compliance, support, and follow-up during this period must be prompt. Telemedicine offers this assistance since long waiting lists make it difficult to provide such support. Several studies suggest that patients in the telemedicine group expressed high satisfaction with their care. They especially liked the convenience of a live video visit with a sleep doctor. Instead of replicating traditional visits, mHealth can provide shorter and more frequent assessments; alarm systems on patients’ devices can alert physicians, and mobile applications with simple questionnaires may help with follow-up. The sleep apnea market is likely to show growth owing to these potential benefits offered by telemedicine and mHealth in improving sleep apnea diagnosis and management.
Challenge: Poor compliance associated with CPAP
Lack of patient compliance to CPAP therapy is a crucial factor challenging the growth of the market. Treatment compliance has always been an issue with sleep apnea patients, mainly due to various issues such as lack of affordability and comfort. Patients are also not willing to bear heavy treatment costs due to very weak reimbursements in geographies like Asia (India and China) and the rest of the world. Non-compliance is found to be more rampant among CPAP users. According to several studies, compliance essentially means using a CPAP device for more than 4 hours per night on at least 70% of nights. Failure to comply with CPAP therapy occurred in 25% to 50% of patients who abandoned the therapy within the first four weeks of treatment.
Geographical Growth Dynamics:
In 2022, North America to dominate in sleep apnea devices industry
The global sleep apnea devices market is segmented into North America, Europe, Asia Pacific and Rest of World. North America is expected to dominate during the forecast period, primarily due to presence of initiatives such as the CPAP Assistance Program (CAP) and rising number of sleep apnea companies in the US getting private funding for developing and commercializing their sleep apnea products.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=719
Leading Companies:
The sleep apnea devices market is dominated by players such ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare (New Zealand).
Wednesday, June 5, 2024
Medical Equipment Maintenance: Global Revenue Growth Predictions
Study Overview:
This research extensively utilized both primary and secondary sources to examine various industry factors. The goal was to identify market segmentation types, industry trends, key players, competitive landscape, major market dynamics, and strategies of key players.
Major Growth Influencing Factors:
Market growth is driven by the increasing number of diagnostic imaging procedures, a heightened focus on early diagnosis, an expanding patient population, strategic agreements and collaborations between service providers and end users, and the presence of numerous OEMs.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69695102
Primary Research:
During the primary research phase, interviews were conducted with various sources from both supply and demand sides to gather qualitative and quantitative data. Supply side sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from major companies in the medical equipment maintenance market. Demand side sources included medical OEMs, medical device ISOs, and service providers. Primary research aimed to validate market segmentation, identify key market players, and gather insights on industry trends and market dynamics.
Secondary Research:
The secondary research phase involved extensive use of sources such as directories, databases (including Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company documents, investor presentations, and SEC filings. This phase was crucial for gathering technical, market-oriented, and commercial information about the global medical equipment maintenance market. It also provided essential information on key players, market classification, segmentation, and significant industry and technological developments. A database of key industry leaders was also compiled using secondary research.
Projected Surge in Global Revenue:
The global medical equipment maintenance market was valued at $48.8 billion in 2023 and is projected to reach $80.7 billion by 2028, growing at a CAGR of 10.6% from 2023 to 2028.
Data Triangulation:
To finalize the overall market size, the market was divided into segments and subsegments. Data triangulation and market breakdown procedures were used to ensure accurate statistics for all segments. This involved analyzing various factors and trends from both demand and supply sides, and validating the market using both top-down and bottom-up approaches.
Geographical Growth Dynamics:
Germany is expected to register the highest CAGR in the European medical equipment maintenance market during the forecast period. The growth is attributed to the expansion of service providers (both OEMs and ISOs, as well as in-house maintenance), evolving healthcare infrastructure post-COVID-19, and a favorable investment climate in the country. Europe includes Germany, France, the UK, Italy, Spain, and the rest of Europe.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=69695102
Key Players:
As of 2022, prominent players in medical equipment maintenance are GE Healthcare Technologies Inc. (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), and FUJIFILM Holdings Corporation (Japan) among others.
Respiratory Care Devices Market: Driver, Restraint, Opportunity & Challenge
Overview of This Study:
This research employed a large number of primary and secondary sources. In order to determine the segmentation kinds, industry trends, major players, competitive landscape, important market dynamics, and major player strategies, the research procedure entailed analyzing a variety of industry-affecting aspects.
Major Revenue Growth Dynamics:
Revenue from respiratory care devices was projected to reach $21.8 billion globally in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 7.8% to $31.8 billion by 2028.
Download PDF Brochure for More Details@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=368
Driver: Rising Prevalence of Respiratory Diseases
Prolonged exposure to tobacco smoking, indoor and outdoor air pollution, and occupational dust and fumes are some of the main causes of COPD. COPD is associated with other concomitant chronic illnesses, such as diabetes mellitus, musculoskeletal disability, and cardiovascular disease. In addition to interfering with the management of COPD, these disorders may also have an effect on patients' health. Asthma claimed the lives of 0.5 million people in 2019 and affected around 262 million people worldwide, according to the WHO. Morbidity and mortality in asthma remain significant problems, and no medication can bring the disease back to baseline.
Globally, there will likely be an increase of 100 million asthmatic sufferers by 2025. One in twelve Americans suffer with asthma, and over ten million adults over 45 in Europe suffer from the illness. Up to 1,000 people are thought to pass away from asthma-related causes every day.
Restraint: Unfavorable reimbursement scenario
For therapy, a lot of patients depend on reimbursements. The issue of unpaid bills for different diagnostic tests is currently plaguing the diagnostic sector overall and respiratory care diagnostics specifically. The 2020 Medicare Physician Fee Schedule was made public by the Centers for Medicare & Medicaid Services (CMS) on November 1st. The final payment rates for home sleep testing are in line with the CMS's initial modifications, according to the CMS. With a 2% decrease from the previous year, Medicare's national payment rates for CPT 95800 (sleep study, heart rate, oxygen saturation, and simultaneous recording); respiratory analysis, by airflow or peripheral arterial tone; and sleep time) was largely unchanged.
Medicare's global service payment for CPT 95806 (unattended, simultaneous monitoring of respiratory airflow, heart rate and respiratory effort, oxygen saturation, respiratory airflow, and thoracoabdominal movement) is still 15% less than it was the year before. The distinction between the two codes is that CPT 95800 can call for the equipment to measure sleep duration and may involve the use of peripheral arterial tone technology.
Opportunity: Point-of-care Diagnostics
At or close to the location of patient care, point-of-care (POC) testing is carried out. The main drivers creating a niche market potential for POC devices in respiratory diagnostics are improvements in test accuracy and the growing number of diagnostic tests available for various illnesses.
Growing patient self-testing is one of the main factors propelling the POC respiratory illness diagnostics market. In the upcoming years, technological developments that are facilitating microfabrication processes and devising downsizing are anticipated to bolster the trend of POC testing and the treatment of respiratory disorders. Government agencies in rich and developing nations alike have realized that POC technology offers a perfect opportunity to grow public healthcare networks and meet patients' unmet medical needs. Furthermore, POC testing is becoming more and more preferred as the number of qualified technicians in the centralized system declines.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=368
Challenges: Lack of patient compliance
A major problem impeding the market's growth is patient noncompliance with CPAP therapy. Patients with respiratory and sleep-related diseases have historically had trouble adhering to their treatment plans, primarily because of a variety of problems like comfort and cost. Another reason why patients are unwilling to pay for treatment is the extremely low reimbursement rates in regions like Asia (China and India) and the Rest of the World. It is discovered that non-compliance is more common among CPAP users. According to studies, the claustrophobic character of CPAP therapy makes it difficult for between 30% and 50% of patients to continue receiving it.
Geographical Growth Dynamics:
The respiratory care devices market was dominated by the North American segment.
The regions of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa comprise the worldwide respiratory care devices market. The respiratory care devices market was dominated by North America in 2022. The North American market for respiratory care devices is anticipated to increase as a result of the region's sophisticated healthcare infrastructure and high healthcare spending. Throughout the projection period, the US's high prevalence of asthma is anticipated to fuel demand for respiratory care devices.
Tuesday, June 4, 2024
Topical Drug Delivery Market is Expecting Major Revenue Growth by 2027
Market Size Estimation:
The market size estimates and forecasts provided in this study are derived through a mix of the revenue share analysis, pharmaceutical sales approach, primary interviews, and top-down approach (assessment of Individual shares of each topical drug delivery product, route of administration, and facility of use).
Overview of This Study:
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Research Methodologies Opted:
Primary Research:
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side and demand side are detailed below. Industry experts such as CEOs, presidents, vice presidents, directors, marketing directors, marketing managers, and related executives from various key companies and organizations in the topical drug delivery industry were interviewed to obtain and verify both the qualitative and quantitative aspects of this research study. A robust primary research methodology has been adopted to validate the contents of the report and fill in the gaps.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124871717
Secondary Research:
This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and companies’ house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the topical drug delivery market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Projected Surge in Global Revenue:
The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%.
Data Triangulation:
After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.
Geographical Growth Dynamics:
North America accounted for the largest share of the topical drug delivery market in 2021
In 2021, North America accounted for the largest share the topical drug delivery market, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. Market growth in this region is characterized by the availability of favorable reimbursement options, increasing awareness about novel pharmaceutical drug delivery technologies, the implementation of favorable government initiatives, growing affordability and per capita healthcare expenditure, the presence of a large number of global pharmaceutical giants.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=124871717
Leading Companies Operating in This Industry:
The prominent players in the topical drug delivery market are Glenmark Pharmaceuticals Ltd. (India), Galderma (Switzerland), Johnson & Johnson Private Limited (US), GlaxoSmithKline Plc. (UK), Bausch Health Companies Inc. (Canada), Hisamitsu Pharmaceuticals Inc. (Japan), Cipla (India), Bayer AG (Germany), Viatris Inc. (Mylan N.V.) (US), 3M (US), Merck & Co.Inc.. (Germany), Crescita Therpeautics Inc. (Canada), Novartis International AG (Switzerland), Boehringer Ingelheim International GmBH (Germany), Pfizer Inc. (US), Teva Pharmaceuticals Industries Ltd. (Israel), Bristol Myers Squibb (US), Lead Chemical Co., Ltd. (Japan), Purdue Pharma L.P. (US), Lavipharm (Greece), AbbVie Inc. (US), CMP Pharma, Inc. (Germany), Encore Dermatology, Inc. (US), Prosolus Inc. (US), and Rusan Pharma Ltd. (India).
Human Microbiome - Major Revenue Growth is Predicted in Near Future
Overview of this Study:
This study involved four major activities in estimating the current size of the human microbiome market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments.
Major Growth Driving Factors:
The major factors driving the growth of the market are the surging demand for personalized medicine, and growing demand for natural and holistic approaches is expected to propel the growth of the market. However, limited understanding of microbial interactions are expected to restrain market growth to a certain extent.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37621904
Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the total size of the human microbiome market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
# The key players in the industry and market have been identified through extensive secondary research
# The revenues generated from the human microbiome business of leading players have been determined through primary and secondary research
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Projected Surge in Global Revenue:
The global human microbiome market in terms of revenue was estimated to be worth $0.3 billion in 2023 and is poised to reach $1.7 billion by 2029, growing at a CAGR of 36.1% from 2023 to 2029.
Data Triangulation:
After arriving at the overall market size from the market size estimation process, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition:
The human microbiome refers to a collection of microorganisms, including bacteria, viruses, fungi, and other microbes, that live within and on the human body. These microorganisms interact with each other and with the human host in a complex and dynamic manner, playing important roles in a range of physiological processes, including digestion, immune function, and metabolism. The human microbiome is highly diverse and varies between individuals and different regions of the body. The market encompasses various sectors, including research tools, diagnostics, therapeutics, and consumer products, aimed at leveraging the knowledge and potential of the microbiome to improve human health and well-being.
This includes the development and commercialization of microbiome-based therapies, such as live biotherapeutic products (LBPs), probiotics, prebiotics, and other microbial interventions, as well as the development of diagnostic tools for assessing and monitoring the microbiome.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=37621904
Key Players:
The market for human microbiome is highly consolidated, with key players strategizing to capture the market. Prominent players in the human microbiome market are Seres Therapeutics, Inc. (US), Enterome (France), 4D pharma plc (UK), International Flavors & Fragrances Inc. (US), OptiBiotix Health Plc (UK), Ferring Pharmaceuticals (Switzerland), Synlogic, Inc. (US), Second Genome, Inc. (US), Vedanta Biosciences, Inc. (US), YSOPIA Bioscience (France), FlightPath Biosciences, Inc. (US), Finch Therapeutics Group, Inc. (US), AOBiome Therapeutics (US), BioGaia (Sweden), Quantbiome, Inc. (dba Ombre) (US), Viome Life Sciences, Inc. (US), BIOHM Health (US), DayTwo (US), Atlas Biomed (UK), Bione Ventures Private Limited (India), Luxia Scientific (France), Metabiomics (US), Sun Genomics (US), Seed Health (US), and Gnubiotics Sciences (Switzerland).
Friday, May 31, 2024
Emerging Trends in the Electrosurgery Industry
Introduction:
The electrosurgery industry is undergoing significant transformation, driven by advancements in technology, growing demand for minimally invasive procedures, and increasing healthcare expenditure. Here are the key emerging trends shaping the future of this sector:
1. Technological Advancements:
The electrosurgery market is experiencing rapid technological innovations. Enhanced electrosurgical devices now offer greater precision, safety, and efficiency. These advancements include the integration of advanced energy sources like ultrasonic and radiofrequency technologies, which allow for more precise cutting and coagulation with minimal thermal damage to surrounding tissues. Additionally, the development of intelligent electrosurgical systems equipped with feedback mechanisms ensures optimal energy delivery, reducing the risk of complications.
2. Rise of Minimally Invasive Surgery:
Minimally invasive surgical (MIS) techniques are increasingly preferred over traditional open surgeries due to their numerous benefits, including reduced pain, shorter hospital stays, and quicker recovery times. Electrosurgery plays a crucial role in MIS by enabling surgeons to perform delicate procedures through small incisions. The trend towards MIS is expected to continue, driving the demand for advanced electrosurgical instruments.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142006761
3. Integration with Robotics and AI:
The integration of robotic-assisted surgical systems and artificial intelligence (AI) is revolutionizing the electrosurgery field. Robotic systems provide enhanced dexterity and precision, while AI algorithms assist in planning and executing complex surgical procedures. This combination enhances surgical outcomes and expands the capabilities of electrosurgical techniques in complex and delicate operations.
4. Growing Applications in Various Medical Specialties:
Electrosurgery is being increasingly utilized across various medical specialties, including dermatology, gastroenterology, gynecology, and oncology. In dermatology, for instance, electrosurgical devices are used for the removal of skin lesions and in cosmetic procedures. In oncology, electrosurgery aids in the precise removal of tumors while preserving healthy tissue. This diversification of applications is broadening the market's scope and driving growth.
5. Emphasis on Patient Safety and Regulatory Compliance:
With the growing focus on patient safety, regulatory bodies are imposing stringent guidelines for the approval and use of electrosurgical devices. Manufacturers are required to adhere to rigorous standards to ensure the safety and efficacy of their products. This trend is leading to the development of devices with improved safety features, such as automated energy control and real-time monitoring systems.
6. Market Growth and Strategic Collaborations:
The global electrosurgery market is projected to witness significant growth, driven by increasing healthcare expenditure, rising prevalence of chronic diseases, and the growing geriatric population. Companies are engaging in strategic collaborations, mergers, and acquisitions to expand their product portfolios and geographical presence. These collaborations are fostering innovation and enabling companies to meet the evolving needs of the healthcare industry.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=142006761
Conclusion:
The electrosurgery industry is at the forefront of surgical innovation, with emerging trends focused on enhancing precision, safety, and efficiency. The ongoing advancements in technology, coupled with the rising demand for minimally invasive procedures and strategic industry collaborations, are set to drive the growth of the electrosurgery market in the coming years.
Wednesday, May 29, 2024
Future Growth Trends in Pharmaceutical Drug Delivery
Major Growth Influencing Factors:
Increased R&D spending, the expanding biologics market, the emergence of new products, the growing prevalence of chronic illnesses, and technology breakthroughs are all major contributors to the growth of the pharmaceutical drug delivery sector. Additionally, research and development (R&D) is a priority for pharmaceutical and biopharmaceutical businesses as they create novel compounds for a range of therapeutic uses and drug delivery systems.
The companies invest heavily in R&D with the aim of delivering high-quality and innovative products to the market. R&D spending by biopharmaceutical companies has also increased over the years. On the other hand, the risk of needlestick injuries and the increased pricing pressure are expected to limit the market's growth to some extent in the coming years.
Market Size Estimation:
Following data triangulation from various methods, the pharmaceutical medication delivery market's overall size was determined, as will be discussed below. Based on the degree of assumptions made in each method, a weighted average of the techniques was determined after each one.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1085
Major Surge in Global Revenue:
The size of global pharmaceutical drug delivery market in terms of revenue was estimated to be worth $1,656.9 billion in 2021 and is poised to reach $2,206.5 billion by 2026, growing at a CAGR of 5.9% from 2021 to 2026.
Data Triangulation:
After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Opportunity: Self-management and in-home care
Players in the pharmaceutical drug delivery market could see substantial growth prospects from self-administration and home care. The primary cause of this is the growing geriatric population, as they represent a significant market for home care medication delivery equipment. This aspect is also driving up demand for application-specific topical, injectable, inhalation, and transdermal medication treatments that meet patients' and caregivers' demands.
Challenge: Pressure on prices
Government agencies are pushing cost-cutting initiatives including lowering prescription reimbursement rates and encouraging the use of generics more frequently in both developed and developing nations. Government agencies, insurers, and patients are putting tremendous pressure on drug makers worldwide to reduce costs. Because there is a significant demand for affordable treatments in emerging countries, there is a greater adoption of pharmaceuticals as a result of this lower pricing pressure.
Still, this is hurting a number of pharmaceutical companies' bottom lines. Due to constant pressure from pharmacy benefit managers (PBMs), insurers, and public and private payers to lower pharmaceutical prices because they are worried about paying for more new medications to treat common conditions like diabetes and high cholesterol, this trend is anticipated to continue in the upcoming years.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1085
Geographical Growth Scenario:
North America will dominate the pharmaceutical drug delivery industry from 2021–2026
Geographically, the global pharmaceutical drug delivery market is segmented into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. North America accounted for the largest share of this market in 2020. The high share of the North American market is attributed to the rising prevalence of chronic diseases, such as cancer, respiratory allergies, and diabetes; increasing patient compliance with innovative drug delivery technologies; and the presence of a large number of prominent players in this region.
Dental Consumables Market - Major Revenue Surge is Predicted in Near Future
https://www.marketsandmarkets.com/requestsampleNew.asp?id=699
Tuesday, May 14, 2024
Pharmaceutical Drug Delivery: Emerging Trends to Bring Major Transformation in Near Future
Overview of This Study:
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Revenue Growth Predictions:
With a compound annual growth rate (CAGR) of 5.9%, the global pharmaceutical medication delivery industry is expected to reach $2,206.5 billion by 2026 from its anticipated $1,656.9 billion in revenue in 2021. The research report includes a price analysis, patent analysis, conference and webinar materials, important stakeholders, purchasing patterns in the market, and an analysis of industry trends.
Major Growth Driving Factors:
Growth in the pharmaceutical drug delivery industry can largely be attributed to factors such as the rising prevalence of chronic diseases, the growing biologics market, increasing R&D investments, technological advancements, and new product launches. Moreover, pharmaceutical and biopharmaceutical companies are focusing on R&D to develop new molecules for various therapeutic applications and drug delivery platforms. The companies invest heavily in R&D with the aim of delivering high-quality and innovative products to the market. R&D spending by biopharmaceutical companies has also increased over the years. On the other hand, the risk of needlestick injuries and the increased pricing pressure are expected to limit the market's growth to some extent in the coming years.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1085
The infectious disease segment accounted for the largest share of the pharmaceutical drug delivery industry
On the basis of application, the pharmaceutical drug delivery market is segmented into cancer, infectious diseases, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other applications. In 2020, the infectious diseases segment accounted for the largest share of the global market. The large share of this market segment can be attributed to the increasing prevalence of infectious diseases across the globe, increasing R&D expenditure for new drugs owing to the current COVID-19 pandemic scenario, and the rising number of FDA approvals for such drugs.
Geographical Growth Dynamics:
From 2021 to 2026, North America will lead the pharmaceutical drug delivery sector.
The pharmaceutical drug delivery market is divided geographically into the following regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2020, North America held the biggest market share in this industry. The rising incidence of chronic illnesses like diabetes, cancer, and respiratory allergies as well as patient compliance with novel drug delivery technologies and the concentration of major players in this region are all considered to be contributing factors to the market's high share in North America.
Driver: Growth in biologics market
Enterprises like Evonik (Germany) have realized the potential of biologics production and have taken significant strategic steps forward. For example, in 2021 the business acquired SurModics, a company that specializes in controlled-release parenteral applications, in order to expand its production capacity. To further strengthen its position in this industry, Evonik also purchased related technology, such as the RESOMER platform from Boehringer Ingelheim. In a similar vein, WuXi Biologics and Shanghai Hile Bio-Technology Co., Ltd. announced the establishment of WuXi Vaccines in 2019. The two businesses forged a strategic alliance whereby WuXi Vaccines will construct a special facility and provide a commercial product for the international market. A new class of medicines has emerged in the biopharmaceutical industry, demonstrating great promise for novel therapies in diabetes, cancer, and other disease areas.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1085
Leading Companies:
Major players in this market include Johnson & Johnson (US), Novartis International AG (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Pfizer Inc. (US), Bayer AG (Germany), Antares Pharma, Inc. (US), Becton, Dickinson and Company (US), GlaxoSmithKline plc (UK), 3M (US), Merck & Co., Inc. (US), Sanofi (France), Amgen, Inc. (US), AbbVie Inc. (US), Genmab A/S (Denmark), Gilead Sciences, Inc. (US), Boehringer Ingelheim (Germany), AstraZeneca plc. (UK), Eli Lilly and Company (US), Teva Pharmaceuticals Industries Ltd. (Israel), Bristol-Myers Squibb (US), Gerresheimer AG (Germany), Boston Scientific Corporation (US), Nimbus Therapeutics (US), Kite Pharma (US), and IDEAYA Biosciences, Inc. (US).
Wednesday, April 10, 2024
Tablet Coatings Market - Emerging Trends to Bring Major Revolution in Global Healthcare Industry
Market Size Estimation:
This study's market size estimations and forecasts are the result of combining a top-down (evaluation of utilization/adoption/penetration trends by polymer type, functionality, type, end user, and region) and bottom-up (segmental analysis of important segments) methodology.
Projected Surge in Revenue Generation:
With a compound annual growth rate (CAGR) of 5.6%, the tablet coatings market is expected to reach a valuation of USD 969 million by 2025 from its estimated USD 739 million in 2020.
Major Growth Boosting Factors:
The pharmaceutical industry's growth and the rise in R&D in this area are the main factors driving this market's expansion. The market is expanding thanks to the burgeoning nutraceutical business, the fast expanding biopharmaceuticals sector, the growing generics market, and the increased use of orphan medications. Furthermore, there are a lot of prospects for market expansion due to the pharmaceutical industry's growing emphasis on emerging markets and the growing outsourcing of operations to these nations. The growing emphasis on technology developments in specialized markets also presents large growth prospects for companies involved in this industry.
However, throughout the projected period, the market's expansion is anticipated to be constrained by the tightening regulations pertaining to the licensing of pharmaceuticals and excipients, as well as the high cost of the microencapsulation process.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150774403
Data Triangulation:
The entire tablet coatings market was split into a number of categories and subsegments when the market size was determined. In order to finalize the market engineering process and obtain precise statistics for every segment and subsegment, data triangulation and market breakdown techniques were utilized, if appropriate.
End Users:
The pharmaceutical industry end-user segment is expected to account for the largest share of the tablet coatings market
The tablet coatings market, by end-user, is segmented into pharmaceutical and nutraceutical industry. The pharmaceutical industry segment accounted for the largest market share in 2019. The demand for tablet coatings in the pharmaceutical industry is largely driven by the increasing number of drugs launched as tablet formulations and growing prevalence of diseases for which tablet-based formulations form the primary treatment. The rising demand for innovative drug delivery formulations is also supporting the growth of the tablet coatings market for the pharmaceutical industry.
Geographical Growth Dynamics:
Asia Pacific is expected to account for the highest CAGR for players operating in the tablet coatings market
The Asia Pacific tablet coatings market is expected to grow at the highest CAGR from 2020 to 2025. Increase in outsourcing of drug manufacturing to specialized contract manufacturing organizations (CMOs), rising number of companies setting up manufacturing units in these countries, favorable government regulations, low labor and manufacturing costs, and the large base for the generation of generics & biologics are factors expected to drive the growth of the market during the forecast period.
Global Key Players:
The prominent players in this market are Colorcon Inc. (US), Sensient Technologies Corporation (US), BASF SE (Germany), Evonik Industries AG (Germany), Ashland Global Holdings Inc. (US), DuPont De Numeours Inc. (US), Kerry Group plc (Ireland), Roquette Freres (France), Eastman Chemical Company (US), Air Liquide S.A. (France), and Merck KGaA (Germany).
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=150774403
Thursday, March 28, 2024
Contrast Media Market: A Major Revenue Surge is Predicted at a CAGR of 7.5% by 2029
Principal Growth-Inducing Factors:
Growing numbers of hospitals and diagnostic imaging facilities, increased awareness of early diagnosis, and an increase in the prevalence of chronic illnesses are the main factors driving market expansion. Conversely, the negative consequences linked to the usage of contrast media will limit this market's expansion somewhat.
Projected Surge in Global Revenue:
According to revenue estimates, the global contrast media market will be valued $6.3 billion in 2023 and is expected to rise at a compound annual growth rate (CAGR) of 7.5% to reach $9.7 billion by 2029.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911
Global Industry Segmentation:
By application, the radiology segment held the biggest proportion of the contrast media market in 2022.
The contrast media market is divided into three segments based on application: interventional radiology, radiology, and interventional cardiology. By application, radiology held the biggest market share in 2022. radiological contributes to the increased demand for radiological operations by being essential in the early detection and monitoring of a variety of medical problems. The growing number of elderly people, the occurrence of chronic illnesses, and the need for minimally invasive procedures are just a few of the reasons for the high percentage of radiology applications.
By route of administration, the intravascular route segment held the biggest proportion of the contrast media market in 2022.
The global contrast media market is divided into intravascular, oral, rectal, and other routes of administration based on the mode of administration. According to the mode of administration, the intravascular route segment had the biggest market share in 2022. The reason for the segment's expansion is because, in contrast to powdered forms, injectable contrast media are more readily available and require less time to administer.
End Users:
According to end users, the Hospitals, Clinics, and Ambulatory Surgical Centers segment held the highest share in the contrast media industry in 2022.
The contrast media market is divided into categories based on the end user, including diagnostic imaging facilities, hospitals, clinics, and ambulatory surgical centers. The global market share held by hospitals, clinics, and ambulatory surgery facilities was the highest in 2022. The need for contrast media is increased because hospitals often make larger investments in and keep a wider variety of cutting-edge imaging equipment, including CT scanners, MRI machines, and interventional radiology suites.
Geographical Growth Scenario:
The contrast media industry's largest share was held by North America in 2022.
There are four main regions that make up the contrast media market: North America, Europe, Asia Pacific, and the Rest of the World. With the most market share in 2022, North America emerged as the top contributor. The number of product approvals in the region has increased as a result of the presence of significant businesses. These North American-based businesses have a wealth of experience, resources, and established sales networks, which help explain the region's market supremacy.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=911
Global Leading Companies:
The major players operating in this market are GE HealthCare (US), Bracco Imaging S.p.A. (Italy), Bayer AG (Germany), Guerbet (France), Lantheus Medical Imaging (US), Unijules Life Sciences Ltd. (India), JB Pharma (India), Sanochemia Pharmazeutika (Germany), TAEJOON PHARM Co., Ltd. (South Korea), Jodas Expoim (India), iMax Diagnostic Imaging Limited (Ireland), YZJ Group (China), Livealth Biopharma Pvt. Ltd. (India), Unispire Biopharma Private Limited (India), Acro Lifesciences (I) Pvt. Ltd. (India), Stanex Drugs & Chemical Pvt. Ltd. (India), Beijing Beilu Pharmaceutical Co., Ltd. (China), Rege Imaging & Cine Films Private Limited (India), K DIAM EXIM (India), Onko Ýlaç San. ve Tic. A.Þ. (Turkey), Fresenius Kabi (Germany), Biem Ilaç San. ve Tic. A.S. (Turkey), and AdvaCare (US).
Wednesday, March 27, 2024
Cell Isolation Market - Future Revenue Growth Looks More Promising Due to These Factors
Market Size Estimation:
Top-down approach was used to estimate and validate the total size of the cell isolation market. This method was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
The key players in the industry and market have been identified through extensive secondary research
The revenues generated from the cell isolation products business of leading players have been determined through primary and secondary research
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Projected Revenue Surge, Globally:
According to revenue estimates, the global cell isolation market will be valued $4.4 billion in 2023 and is expected to increase at a compound annual growth rate (CAGR) of 13.4% from 2023 to 2028, when it reaches $8.2 billion. The market's industry trends are analyzed in the latest research study.
Major Growth Driving Factors:
The market is expanding due to factors like the rise in cell-based research and the growing emphasis on personalized therapy. However, the main things impeding the growth of this market are high cost, safety concerns, and ethical considerations.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479
Data Triangulation:
Following the completion of the market size assessment process, the entire market was divided into a number of segments and sub-segments. Data triangulation and market breakdown processes were used where appropriate to finish the entire market engineering process and yield precise statistics for all segments and subsegments. Through an analysis of numerous variables and patterns from the supply and demand sides, the data was triangulated.
Driver: Government support for cell-based research has increased.
The crucial first stage in the development of cell-based therapies is cell isolation. Because cell-based research has many applications, funding for these kinds of studies has been provided by numerous governments worldwide. The National Institutes of Health (NIH), for example, stated in May 2021 that funding totaling USD 30.0 million will be given to assist research targeted at creating new instruments and technology for researching cells. A number of US universities, including Harvard University, the University of California, San Francisco, and the University of Texas Southwestern Medical Center, received financing. Moreover, the Stem Cell Therapies Mission is investing USD 150.0 million over a ten-year period under the Medical Research Future Fund (MRFF) of the Government.
RESTRAINT: Ethics and safety concerns will impede commercial expansion
The embryo from which the cells are formed must be destroyed in order to isolate the embryonic stem cells. Given that some people believe an embryo to be a potential human person, this creates ethical questions regarding the taking of human life. Teratomas are tumors that comprise cells from all three germ layers, and they can be formed by embryonic stem cells. Without adequate screening, embryonic stem cells put into a patient have the potential to develop into tumors and cause damage. As a result, these elements may hinder market expansion to some degree.
Opportunity: Prospects for expansion in developing economies
The biopharmaceutical sector is expanding quickly in emerging nations like China, India, and Brazil. This is caused by a number of causes, including rising healthcare costs, an aging population, and an increase in chronic illnesses. The necessity for cell separation technologies is driving the development and manufacturing of biopharmaceuticals, as these markets see an increase in demand for these goods. Furthermore, growing markets are funding the creation and use of cutting-edge technologies including flow cytometry, magnetic cell separation, and microfluidics.
As a result, cell isolation procedures are becoming more accurate and efficient, and these technologies are becoming more widely available and reasonably priced in these markets. Additionally, there is an increasing trend in emerging markets for R&D activity. In these areas, public and private organizations are funding research to create novel cures and treatments for long-term illnesses. Since cell isolation is a crucial stage in the creation of various treatments, the market is expanding as a result of the expansion of research efforts in these areas.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479
North America dominated cell isolation market in 2022.
Geographically, the market is divided geographically into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held the greatest market share for cell isolation in 2022, followed by Europe and the Asia-Pacific region. A number of variables, including technical development, expansion of the biotechnology and pharmaceutical industries, and rising incidence of infectious and chronic diseases, account for the major share of the American market.
Leading Companies Operating in This Industry
Key players in the cell isolation market are Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Corning Incorporated (US), F. Hoffmann-La Roche Ltd. (Switzerland), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Alfa Laval (Sweden), Sartorius AG (Germany), Akadeum Life Sciences (US), Bio-Techne (US), PerkinElmer Inc. (US), Invent Biotechnologies, Inc. (US), Takara Bio, Inc. (Japan), MiCareo Inc. (US), Proteintech Group, Inc. (US), QIAGEN (Germany), Lonza (Switzerland), Promega Corporation (US), PluriSelect Life Science UG (Haftungsbeschränkt) & Co. KG (Germany), and MagBio Genomics (US).